The TIGIT gene helps put a brake on certain immune cells, especially T cells and natural killer cells, so your immune system stays balanced and does not react too strongly. If this gene does not work as it should, immune activity may become harder to control, which can raise inflammation or contribute to autoimmune disease. In medicine, this gene is important because it helps regulate immune cells that can become worn out in some cancers and long lasting infections.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the functional parts of cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, and medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
TIGITGene function
What if the gene works
The TIGIT gene helps control immune cells called T cells and natural killer cells. Its protein acts like a brake, helping limit inflammation and prevent immune responses from becoming too strong.
Risk
What if the gene does not work
Milder to more severe variants in the TIGIT gene can reduce or disrupt this immune brake on T cells and natural killer cells. This may weaken inhibitory signaling and make immune activity less tightly controlled.
Treatment
What does that mean for your treatment
No TIGIT-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the TIGIT gene. TIGIT is an active drug target in cancer immunotherapy, and medicines that block TIGIT are being studied to help immune cells respond more strongly to some tumors.
Gene function
What if the gene works
The TIGIT gene helps set the pace of immune activity, especially in T cells and natural killer cells. Its protein sits on the cell surface and passes calming signals between immune cells. Understanding how the TIGIT gene helps regulate immune cells makes it easier to see how your body keeps defense effective but controlled.
The TIGIT gene helps activated T cells and natural killer cells ease off when a response needs control. Its surface protein sends inhibitory signals that keep immune activity measured rather than constantly pushed forward.
Its protein recognizes partner molecules called CD155 and CD112 on nearby cells. That contact works like a quiet stop signal, helping immune cells adjust their behavior in real time.
One of the main roles of the TIGIT gene is to balance activating signals from other immune receptors. By sharing partner proteins with CD226, it helps fine tune how strongly immune cells react.
In normal immune function, the TIGIT gene helps the body stay tolerant to everyday exposures and to its own tissues. This supports a steady immune response that can defend the body without unnecessary inflammation.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TIGIT gene can change how the TIGIT receptor is made, how much reaches the cell surface, or how well it binds partner proteins such as CD155. In understanding how TIGIT gene variants affect immune signaling, milder variants may only slightly reduce receptor stability or signaling, while more severe variants can greatly weaken or abolish this inhibitory signal. Some changes may also alter how TIGIT interacts with other immune checkpoint pathways.
How variants are linked to conditions
Variants in the TIGIT gene do not yet have a broadly confirmed link to a specific health condition, though research on TIGIT gene variants and health conditions is still developing. Anyone with a reported variant in the TIGIT gene should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a normal, common feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TIGIT gene. If TIGIT is part of your test results and you are concerned about what it may mean for you or your family, a doctor or genetic counselor can help put it in context.
Inheritance of TIGIT variants
There is not yet a broadly confirmed Mendelian pattern for how TIGIT-related health effects are passed down, so the answer to how variants of the TIGIT gene are inherited is still developing. At present, TIGIT is studied more as a risk-influencing gene than as a gene with one clearly established dominant or recessive condition. The TIGIT gene is located on chromosome 3, which is an autosome, so you inherit one copy from each parent.
What does my TIGIT result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific TIGIT-related condition. If you have a TIGIT result and want to know what it could mean for relatives, the answer depends on the exact change found and why the test was done.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the TIGIT gene, a lab can analyze DNA from a blood, saliva, or cheek swab sample. Genetic testing for TIGIT variants reads the gene’s DNA code and checks for changes, then compares any findings with reference data to classify them as benign, uncertain, or clinically relevant.
When should I consider getting a genetic test?
There is not yet a broadly established, TIGIT-specific reason for most people to get genetic testing. Testing decisions are usually based on personal health and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the kind of variant involved. Over time, how the body works is also shaped by factors such as age, lifestyle, environment, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This is common and can influence how well a treatment works or how likely someone is to notice side effects or increased sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how the body processes a drug or how strong its effects are. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the TIGIT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines or side effects are best discussed with your doctor. TIGIT is being studied in cancer immunotherapy research, but it is not currently used in routine prescribing decisions.
History
The TIGIT gene entered the scientific literature in the late 2000s, when researchers studying immune signaling identified it as part of a growing group of checkpoint genes. Its discovery came during a period of rapid progress in cancer immunology, as scientists were mapping the signals that can dial immune activity up or down. From these first observations, research expanded steadily into how the TIGIT gene might shape immune responses in cancer, infections, and autoimmune conditions. Interest in this gene grew further as drug developers began testing medicines designed to block the TIGIT pathway. While it has not become a household name, the TIGIT gene is now a recognized part of modern immunotherapy research.